RLAY β€” Relay Therapeutics Inc

Ownership history in Alphabet Inc.  Β·  14 quarters on record

This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Relay Therapeutics Inc (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.79% (2022 Q3)
πŸ“Š Avg. % of fund
0.76%
πŸ“… First filed
2022 Q3
πŸ“… Last filed
2025 Q4
⏱ Quarters held
14

Position Intelligence

Alphabet Inc. Γ— RLAY AI Analytics

πŸ“‰ Alphabet Inc. underperformed the S&P 500 by –28.3% annually on this RLAY position. Average cost basis: $22.37. Maximum drawdown during holding period: –88.3%.

πŸ“ˆ Position Alpha vs SPY
-28.3%
annualised excess return

❌ Significantly underperformed the S&P 500 by 28.3% ann.
13 quarters analyzed

πŸ’° Entry Quality
$22.37
-62.2% vs current ($8.46)

Best entry: $22.37 (2022 Q3)  Β·  Worst: $22.37 (2022 Q3)

πŸ›‘οΈ Drawdown Resilience
–88.3%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

1 add Β· 0 trims. Bought during 0 of 7 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.51% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    RLAY price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,568,753 β€” 0% 0.51% $13.3M $8.46
2025 Q3 UNCHANGED 1,568,753 β€” 0% 0.34% $8.2M $5.22
2025 Q2 UNCHANGED 1,568,753 β€” 0% 0.25% $5.4M $3.46
2025 Q1 UNCHANGED 1,568,753 β€” 0% 0.26% $4.1M $2.62
2024 Q4 UNCHANGED 1,568,753 β€” 0% 0.38% $6.5M $4.12
2024 Q3 UNCHANGED 1,568,753 β€” 0% 0.60% $11.1M $7.08
2024 Q2 UNCHANGED 1,568,753 β€” 0% 0.52% $10.2M $6.52
2024 Q1 UNCHANGED 1,568,753 β€” 0% 0.52% $13.0M $8.30
2023 Q4 UNCHANGED 1,568,753 β€” 0% 0.80% $17.3M $11.01
2023 Q3 UNCHANGED 1,568,753 β€” 0% 0.85% $13.2M $8.41
4 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding RLAY

As of 2025 Q4 β€” sorted by position size

Commodore Capital LP 3Y 9.57% Casdin Capital, LLC 3Y 7Y 6.83% Foresite Capital Management IV, LLC 3Y 7Y 3.68% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 2.36% MPM BioImpact LLC 3Y 2.16% Elmind Capital, LP 1.34% Bellevue Group AG 3Y 7Y 1.34% HighVista Strategies LLC 3Y 7Y 1.19% TCG Crossover Management, LLC 3Y 0.9% Kynam Capital Management, LP 3Y 0.77%
← Back to Alphabet Inc. Holdings